Medical Device Regulatory Market Access in Times of a National Emergency
Hosted by the University of Illinois, this special webinar was developed to explain what non-medical manufacturers need to know to help alleviate supply shortages of critically needed medical devices in response to the COVID-19 pandemic. Featuring experts from both Emergo by UL and UL LLC, this session addresses a timely issue and will be of interest far beyond the medical device industry.
Presenters:
- Audrey Swearingen, Regulatory Affairs Manager | Emergo by UL
- Michael Wiklund, General Manager - Human Factors Research & Design | Emergo by UL
- James Benscoter, Senior Staff Engineer | UL LLC
- Anura Fernando, Chief Innovation Architect – Medical Systems Interoperability and Security | UL LLC
Questions? Request more information from our specialists
CONTACT USRelated
-
Residual risk analysis of user interaction problems
Residual risk analysis is a process whereby medical device and IVD manufacturers can integrate observed use errors into their design considerations
read more -
Medical Device Regulatory Market Access in Times of a National Emergency
Hosted by the University of Illinois, this special webinar was developed to explain what non-medical manufacturers need to know to help alleviate s
read more